How to use the speech recognition tool?

PROST

Validation of standardized test protocols to assess the impact of visual pathologies in daily life activities

Validation of standardized test protocols to assess the impact of visual pathologies in daily life activities.

Type: Interventional



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2019-10-04
  • Closing Date: 2021-03-01

Criteria

Inclusion: Gr1 affected patients: Diagnosed non-syndromic pigmentary retinopathy (RP) Gr 2 healthy patients: Visual acuity of both corrected eyes (glasses, lenses) greater than or equal to 8/10 (or ≤ 0.1 logMAR)

Exclusion: MMSE score without visual item ≤ 20/25 for RP patients MMSE score with visual item ≤ 25/30 for healthy volunteers Pregnant woman

Children: No

Adults: Yes

Funder Type: private, public

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: